Lineage Cell Therapeutics (LCTX)
(Delayed Data from AMEX)
$0.90 USD
+0.02 (2.51%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $0.90 0.00 (-0.30%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.04 |
EPS Last Quarter | -0.03 |
Last EPS Surprise | 25.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.16 |
Next Year | -0.12 |
EPS (TTM) | -0.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.84M | 14.35M | 18.05M | 14.32M |
# of Estimates | 2 | 3 | 3 | 2 |
High Estimate | 4.83M | 35.30M | 35.30M | 25.30M |
Low Estimate | 0.84M | 0.84M | 3.95M | 3.34M |
Year ago Sales | 1.25M | 2.09M | 8.94M | 18.05M |
Year over Year Growth Est. | 126.80% | 586.60% | 101.79% | -20.66% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.04 | 0.02 | -0.16 | -0.12 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | -0.05 | 0.13 | -0.16 | -0.08 |
High Estimate | -0.03 | 0.13 | -0.12 | -0.08 |
Low Estimate | -0.05 | -0.04 | -0.20 | -0.16 |
Year ago EPS | -0.04 | -0.03 | -0.12 | -0.16 |
Year over Year Growth Est. | 0.00% | 166.67% | -33.33% | 25.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.04 | 0.02 | -0.16 | -0.12 |
7 Days Ago | -0.04 | 0.02 | -0.16 | -0.12 |
30 Days Ago | -0.04 | 0.02 | -0.16 | -0.12 |
60 Days Ago | -0.04 | 0.02 | -0.16 | -0.12 |
90 Days Ago | -0.04 | 0.02 | -0.16 | -0.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.04 | 0.02 | -0.16 | -0.12 |
Zacks Consensus Estimate | -0.04 | 0.02 | -0.16 | -0.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.03 | -0.04 | -0.03 | -0.04 | NA |
Estimate | -0.04 | -0.04 | -0.07 | -0.04 | NA |
Difference | 0.01 | 0.00 | 0.04 | 0.00 | 0.01 |
Surprise | 25.00% | 0.00% | 57.14% | 0.00% | 20.54% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more